This is actually what I said:
“It will likely be a couple of years until our expansion is built, afaict, and then some time to get it humming along….”
And it was in the context of the current Li prices being not that relevant to our production from that expansion, and in relation to this notion that no-one will fund it because current prices are low.
So yeah, roughly a couple of years. I reckon.
Could it be a bit more? Sure, but to me that matters little.
Today’s prices will be long forgotten by then.
re demand: DYOR on various forecasts for battery demand growth - none of them show that cooling off in any meaningful way afaict.
ps.
Imo there is much more likely to be downside risk on supply growth than on demand growth.
History shows that issues and delays are par for the course. Not to mention the issues arising with some of that rushed supply coming out of China recently wrt enviro concerns etc.
pps.
“Our supply/demand models correlate oversupplied conditions in late-2023 with observed price pressure. We see a reverse to strong deficits from Q3 2024 due to seasonal demand pull, which fundamentally, should see prices rise in this timeframe.”
“To reconcile mined supply to deployed lithium, we assume a 6-month lag between production and end-use consumption, analogous to real world transient effects.
Our analysis expects a small structural deficit in Q2 2024, growing to more pronounced volumes in Q3 and Q4 as end-user demand ramps up, fueling the drawdown of LCE inventories and an expected resumption of buying pressure in H2 2024.”
https://www.adamasintel.com/lithium-market-growing-deficit-through-q4-2024/
Time will tell.
- Forums
- ASX - By Stock
- AGY
- Li-related News/Articles/Reports
Li-related News/Articles/Reports, page-8194
-
- There are more pages in this discussion • 728 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add AGY (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
0.007(8.14%) |
Mkt cap ! $135.4M |
Open | High | Low | Value | Volume |
8.9¢ | 9.4¢ | 8.7¢ | $168.6K | 1.860M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 299999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.090 |
3 | 472915 | 0.089 |
3 | 78883 | 0.088 |
2 | 184482 | 0.087 |
4 | 164883 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 299999 | 1 |
0.094 | 14000 | 1 |
0.095 | 269294 | 3 |
0.096 | 405763 | 3 |
0.097 | 50000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |